Tuberculosis - Learning the Effect of Parasites and Reinforcing Diets
NCT05048485 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 141
Last updated 2025-11-04
Summary
The objectives of this research are to determine:
* the burden of intestinal parasitic infections among persons living with pulmonary tuberculosis (TB)
* whether intestinal parasitic infections alter TB treatment outcomes, including speed of sputum clearance and treatment outcomes
* the impact of malnutrition on speed of sputum clearance and TB treatment outcomes
* whether nutritional supplementation improves speed of sputum clearance and treatment outcomes
In this study the researchers will investigate how intestinal parasites impact the nutritional status of TB patients before the start of nutritional supplementation and how they alter the trajectory of weight gain in those receiving supplementation by analyzing results from 2 cohorts.
LEOPARD Cohort 1-
* Control-Enroll TB cases, screen for undernutrition, obtain stool for intestinal parasite screening by polymerase chain reaction (PCR), and assess them for treatment outcomes and weight gain
* TB LION (Learning Impact of Nutrition) - Enroll TB cases, provide nutritional supplementation for 6 months (as part of existing TB LION study), screen for undernutrition, obtain stool for intestinal parasite screening by PCR, and assess them for treatment outcomes and weight gain
LEOPARD Cohort 2 -
* Enroll TB cases, screen for undernutrition, obtain stool for internal parasite screening by PCR, and assess them for treatment outcomes and weight gain.
Conditions
- Tuberculosis, Pulmonary
- Helminthiasis
- Malnutrition
Sponsors & Collaborators
-
Jawaharlal Institute of Postgraduate Medical Education & Research
collaborator OTHER_GOV -
Boston Medical Center
lead OTHER
Principal Investigators
-
Pranay Sinha, MD · Boston Medical Center
-
Pakrash Babu Narasimhan, PhD · Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-09
- Primary Completion
- 2025-07-21
- Completion
- 2025-07-21
Countries
- United States
- India
Study Locations
More Related Trials
-
The INSTITUT Study Tuberculosis Nutritional Support
NCT06084715 ·Status: COMPLETED
-
Comorbidities and Coinfections in Latent TB
NCT04642755 ·Status: RECRUITING
-
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects
NCT02288481 ·Status: COMPLETED ·Phase: PHASE1
-
Prevention of Tuberculosis in Prisons
NCT03028129 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis
NCT04930978 ·Status: RECRUITING
-
TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB
NCT03251196 ·Status: UNKNOWN
-
Impact of Malnutrition on Pharmacokinetic of Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV Co-infected Children (TB-Speed TB-PK)
NCT04972903 ·Status: COMPLETED
-
The Effect of Parasitic Worm Infections on the Immune Response to Tuberculosis Bacteria
NCT00342017 ·Status: COMPLETED
-
Strengthening Evidence on Optimal Multidrug-resistant Tuberculosis Treatment Regimens
NCT05871489 ·Status: ACTIVE_NOT_RECRUITING
-
Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease
NCT01424501 ·Status: TERMINATED ·Phase: PHASE2
-
A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects
NCT02606214 ·Status: TERMINATED ·Phase: PHASE1
-
Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
NCT04052022 ·Status: RECRUITING
-
Tuberculosis Prevention for HIV Infected Adults
NCT00057122 ·Status: COMPLETED ·Phase: PHASE3
-
Expand New Drugs for TB [endTB]
NCT03259269 ·Status: COMPLETED
-
Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence
NCT03512249 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults
NCT01755598 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety, Tolerability, and Absorption, Metabolism, and Excretion of PA-824 in Healthy Adult Male Subjects.
NCT03202693 ·Status: COMPLETED ·Phase: PHASE1
-
LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea
NCT06946784 ·Status: RECRUITING
-
Evaluation of the Safety, Tolerability, PK of TBAJ-587 in Healthy Adults
NCT04890535 ·Status: COMPLETED ·Phase: PHASE1
-
Deworming Against Tuberculosis
NCT00857116 ·Status: COMPLETED ·Phase: NA
-
Phase IV Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein
NCT05746611 ·Status: COMPLETED ·Phase: PHASE4
-
Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active Pulmonary Tuberculosis
NCT04700579 ·Status: RECRUITING
-
Effect of Weight and/or Obesity on Ethambutol Drug Concentrations
NCT01048697 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination
NCT01119521 ·Status: COMPLETED ·Phase: PHASE1
-
Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)
NCT05401071 ·Status: RECRUITING ·Phase: PHASE2/PHASE3